Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chastagner

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|March 10, 2001
Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP studyF Doz, J C Gentet, F Pein, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2005
Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunctionF Bernard, C Thomas, Y Bertrand, et al.
Medical and Pediatric Oncology|January 1, 1993
Phase II study of ifosfamide in childhood brain tumors: a report by the French Society of Pediatric Oncology (SFOP)P Chastagner, D Sommelet-Olive, C Kalifa, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 6, 2004
[Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use]Y Pérel, D Valteau-Couanet, J Michon, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2003
Individual dosing of carboplatin based on drug monitoring in children receiving high-dose chemotherapyH Rubie, F Doz, G Vassal, et al.
British Journal of Cancer|October 30, 2003
Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapyH Rubie, C Coze, D Plantaz, et al.
Pediatric Blood & Cancer|March 16, 2005
Long-term renal and hearing toxicity of carboplatin in infants treated for localized and unresectable neuroblastoma: results of the SFOP NBL90 studyC Bergeron, L Dubourg, P Chastagner, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2006
High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocolC Dufour, J Grill, A Lellouch-Tubiana, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, O Delattre, O Hartmann, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 27, 2000
[Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists]D Plantaz, J Michon, D Valteau-Couanet, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|March 10, 2001
Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP studyF Doz, J C Gentet, F Pein, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2005
Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunctionF Bernard, C Thomas, Y Bertrand, et al.
Medical and Pediatric Oncology|January 1, 1993
Phase II study of ifosfamide in childhood brain tumors: a report by the French Society of Pediatric Oncology (SFOP)P Chastagner, D Sommelet-Olive, C Kalifa, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 6, 2004
[Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use]Y Pérel, D Valteau-Couanet, J Michon, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2003
Individual dosing of carboplatin based on drug monitoring in children receiving high-dose chemotherapyH Rubie, F Doz, G Vassal, et al.
British Journal of Cancer|October 30, 2003
Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapyH Rubie, C Coze, D Plantaz, et al.
Pediatric Blood & Cancer|March 16, 2005
Long-term renal and hearing toxicity of carboplatin in infants treated for localized and unresectable neuroblastoma: results of the SFOP NBL90 studyC Bergeron, L Dubourg, P Chastagner, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2006
High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocolC Dufour, J Grill, A Lellouch-Tubiana, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, O Delattre, O Hartmann, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 27, 2000
[Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists]D Plantaz, J Michon, D Valteau-Couanet, et al.
Pageof 10